Lipella Pharmaceuticals Inc. (LIPO) Live Share Price, Invest From India

Lipella Pharmaceuticals Inc. Stock Performance

as on July 18, 2026 at 6:40 am IST

Day's High
$0.04
Day's Price Range
$0.06
$0.04
50.00%
Upside
52 Week's Low
52 Week's High
$0.02
52-Week Price Range
$0.32
$0.04
50.75%
Downside
706.00%
Upside

Lipella Pharmaceuticals Inc. share price movements today

Previous Close: $0.06
Open: $0.06
Volume: 3.8M
Day's Low - High: $0.04 - $0.06
52 Week Low - High: $0.02 - $0.32

Lipella Pharmaceuticals Inc. Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Lipella Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Lipella Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$152.5K

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-5.4M

Revenue (TTM)

389.8K

Profit Margin

0.00%

Return On Equity TTM

-361.77%

Lipella Pharmaceuticals Inc. stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Lipella Pharmaceuticals Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Lipella Pharmaceuticals Inc.	BUY	$152.5K	NA	NA	0.00%	NA

Analyst Recommendation on Lipella Pharmaceuticals Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Lipella Pharmaceuticals Inc.. Average target price of $10

Lipella Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Lipella Pharmaceuticals Inc..

What analysts predicted

99.6%UPSIDE

Target Price

$10

Current Price

$0.04

Analyzed by

7 Analysts

Target

$10.00

Lipella Pharmaceuticals Inc. target price $10, a slight upside of 99.6% compared to current price of $0.04. According to 7 analysts rating.

Lipella Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	0	0	0	0	0	0	129	86	-
Gross Profit	-1	0	0	0	0	-1	0	0	0	0
Operating Income	-1	-1	0	-1	0	-1	-1	-1	-1	-1
EBITDA	-1	-1	0	-1	0	-1	-1	-1	-1	-1
Interest Expense	0	-	10	-	-	-	-	-	-	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	0	-1	0	-1	-1	-1	-1	-1
Income Tax Expense	36	33	-58	0	0	-	-	-	-	-
Net Income	-1	-1	0	-1	0	-1	-1	-1	-1	-1
Net Profit Margin	-1442.39%	-1272.04%	-153.22%	-816.98%	-687.63%	-1797.26%	-830.14%	-1.01%	-1.53%	0.00%

Lipella Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	0	0	0
Gross Profit	0	0	-1	-2	-2	-3
Operating Income	0	0	-1	-2	-4	-5
EBITDA	0	0	-1	-2	-4	-5
Interest Expense	0	0	0	0	0	-
Depreciation	-	-	-	-	0	0
Income Before Tax	0	0	-1	-2	-4	-5
Income Tax Expense	0	0	0	0	0	-5,016
Net Income	0	0	-1	-2	-4	-5
Net Profit Margin	-8.90%	-6.41%	-719.30%	-1410.59%	-1027.31%	-935.25%

Lipella Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-1	0	-1	0	-1	-1	-1	-1	-3,885
Operating Cash Flow	0	0	-1	0	0	0	-1	-1	-2,357
Investing Cash Flow	0	-14	-	-	-	-	-	-	-
Financing Cash Flow	0	1	0	-	0	1	3	0	4,210
Change in Cash	0	0	-1	0	0	0	2	-1	1,852

Lipella Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-1	-2	-4	-5
Operating Cash Flow	0	-1	-3	-3
Investing Cash Flow	0	0	0	-
Financing Cash Flow	2	5	1	2
Change in Cash	0	3	-1	-1

Global Institutional Holdings in Lipella Pharmaceuticals Inc.

Funds	Holdings
Tower Research Capital LLC	0%
Mccormack Advisors International	0%
Virtu Financial LLC	0%
Bank of America Corp	0%

About Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania. On March 30, 2026, Lipella Pharmaceuticals Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.

Organisation	Lipella Pharmaceuticals Inc.
Headquarters	7800 Susquehanna St., Pittsburgh, PA, United States, 15208
Industry	Biotechnology
CEO	Dr. Jonathan Kaufman M.B.A., Ph.D.
E-voting on shares	Click here to vote

Key Management of Lipella Pharmaceuticals Inc.

Name	Title
Dr. Jonathan Kaufman M.B.A., Ph.D.	Co-Founder, Chairman, CEO, President, Secretary & Treasurer
Mr. Douglas Johnston CPA	Chief Financial Officer
Ms. Michele Gruber	Director of Operations
Ms. Janet Okonski	Director of Clinical Operations
Katie Johnston	Controller

FAQs

What is Lipella Pharmaceuticals Inc. share price today?

Lipella Pharmaceuticals Inc. share price today is $0.04 as on July 18, 2026 at 1:10 am IST at the close of the market. Lipella Pharmaceuticals Inc. share today touched a day high of $0.06 and a low of $0.04.

What is the 52 week high and 52 week low for Lipella Pharmaceuticals Inc. share?

Lipella Pharmaceuticals Inc. share touched a 52 week high of $0.32 on January 30, 2026 and a 52 week low of $0.02 on April 16, 2026. Lipella Pharmaceuticals Inc. stock price today i.e. July 18, 2026 at 1:10 am IST is closed at $0.04,which is 87.59% down from its 52 week high and 103.05% up from its 52 week low.

What is Lipella Pharmaceuticals Inc.'s market capitalisation today?

Lipella Pharmaceuticals Inc. market capitalisation is $0.00T as on July 18, 2026 at 1:10 am IST.

How to invest in Lipella Pharmaceuticals Inc. Stock (LIPO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lipella Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lipella Pharmaceuticals Inc. Shares that will get you 37.5000 shares as per Lipella Pharmaceuticals Inc. share price of $0.04 per share as on July 18, 2026 at 1:10 am IST.

What is the minimum amount required to buy Lipella Pharmaceuticals Inc. Stock (LIPO) from India?

Indian investors can start investing in Lipella Pharmaceuticals Inc. (LIPO) shares with as little as ₹96.235 or $1 (as of July 22, 2026 at 11:26 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹962.35 in Lipella Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on July 22, 2026 at 11:26 am IST). Based on Lipella Pharmaceuticals Inc. share’s latest price of $0.04 as on July 18, 2026 at 1:10 am IST, you will get 250.0000 shares of Lipella Pharmaceuticals Inc.. Learn more about fractional shares .